| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 02/16/1999 | US5872101 Methods of treating neurodegenerative disorders using protease inhibitors |
| 02/16/1999 | US5872100 Peptides containing D-2-Alkyl-Tryptophan |
| 02/16/1999 | US5872097 Oligopeptides with affinity to opioid receptors |
| 02/16/1999 | US5871938 Detection of protease, incubation, bonding to dna and antibodies |
| 02/16/1999 | US5871711 Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses |
| 02/16/1999 | CA2142297C Liquid detergents containing a peptide aldehyde |
| 02/11/1999 | WO1999006437A1 Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006436A1 Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006435A1 Dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006434A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006433A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006432A1 Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006431A1 Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | WO1999006430A1 Alatrofloxacin parenteral compositions |
| 02/11/1999 | WO1999006391A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof |
| 02/11/1999 | WO1999006390A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | DE19729591A1 Mittel zur Behandlung und/oder Prophylaxe von Mikrozirkulationsstörungen Agents for the treatment and / or prophylaxis of microcirculation disorders |
| 02/11/1999 | CA2291475A1 Dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2291473A1 Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290750A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290749A1 Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290748A1 Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290747A1 Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290746A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/10/1999 | EP0896056A1 Novel thermolysin-like protease and use thereof |
| 02/10/1999 | EP0896003A1 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis |
| 02/10/1999 | EP0896000A1 Process for isolation of 1-[N2-((S-Ethoxycarbonyl)-3-phenylpropyl)-N6-trifluoroacetyl]-L-lysyl-L-proline (Lisinopril (Tfa) ethylester, LPE) |
| 02/10/1999 | EP0777746A4 Assay for the detection of proteases |
| 02/10/1999 | CN1207743A Inhibitors of interleukin-1 'beta' converting enzyme |
| 02/09/1999 | US5869671 Reacting phosphorus pentachloride with amino acid, coupling product with silylated amino acid in nonaqueous solvent to form peptide |
| 02/09/1999 | US5869623 Boronic compound complexing reagents and complexes |
| 02/09/1999 | US5869606 Amino acids peptides or derivatives thereof coupled to fats |
| 02/09/1999 | US5869519 C-terminal modified (n-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/09/1999 | US5869487 Pyrido 3,4-B!pyrazines for use as thrombin inhibitors |
| 02/09/1999 | US5869456 Use of glutathione diesters |
| 02/09/1999 | US5869455 Serine protease inhibitors-N-substituted derivatives |
| 02/09/1999 | US5869454 Arginine keto-amide enzyme inhibitors |
| 02/09/1999 | US5869451 Activate the thrombopoietin receptor. |
| 02/09/1999 | US5869448 Inhibit binding between vla-4 receptor and fibronectin cs-1 peptides; treating immunoinflammatory conditions |
| 02/09/1999 | US5869445 Methods for eliciting or enhancing reactivity to HER-2/neu protein |
| 02/09/1999 | CA1340387C Heterobifunctional coupling agents |
| 02/04/1999 | WO1999005165A1 Streptogramines, their preparation and compositions containing them |
| 02/04/1999 | WO1999005164A1 Process for preparing pharmacologically acceptable salts of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl amino acids |
| 02/04/1999 | DE19832405A1 Isolation of N6-tri:fluoro-acetyl-lisinopril ethyl ester from aqueous solutions |
| 02/04/1999 | CA2299514A1 Streptogramines, their preparation and compositions containing them |
| 02/03/1999 | EP0894003A1 N-formyl hydroxylamine containing compounds useful as ace inhibitors and/or nep inhibitors |
| 02/03/1999 | CN1206715A Amino-acid derivant and preparation process thereof, and medicinal composition containing same |
| 02/03/1999 | CN1041919C N-(3-piperidinylcarbonyl)-beta-alanine derivatives as PAF antagonists |
| 02/02/1999 | US5866685 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 02/02/1999 | US5866681 Oligopeptides |
| 02/02/1999 | US5866679 Peptides |
| 02/02/1999 | US5866604 Thiol derivatives with metallopeptidase inhibitory activity |
| 02/02/1999 | US5866545 Antiinflammatory agents; nervous system disorders; gastrointestinal disorders; urogenital disorders |
| 02/02/1999 | US5866097 Technetium-99m labeled peptides for imaging |
| 01/28/1999 | WO1999003878A2 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
| 01/28/1999 | WO1999003852A1 Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds |
| 01/28/1999 | DE19720165A1 Production of polymeric compounds with nucleo-base substituent(s) |
| 01/27/1999 | EP0765339B1 3-amino-2-oxo-1-piperidineacetic derivatives containing an arginine mimic as enzyme inhibitors |
| 01/27/1999 | CN1206422A Growth-hormone secretagogues |
| 01/27/1999 | CN1041830C Peptide compound |
| 01/26/1999 | US5864024 Synthetic glycoamines and methods for their use that affect cell adhesion, inhibit cancer cell metastasis, and induce apoptosis |
| 01/26/1999 | US5864012 Oligopeptides as antitumor agents |
| 01/26/1999 | US5863950 Amides or thio amide compounds with hydroxy or ether groups |
| 01/26/1999 | US5863937 Peptide conjugated compound as fungicides, bactericides, microbiocides treating candida albicans infection |
| 01/26/1999 | US5863929 Anticoagulant agents |
| 01/26/1999 | US5863902 Methods of treating neurodegenerative disorders using protease inhibitors |
| 01/26/1999 | US5863329 Ceramic composite doctor blade |
| 01/21/1999 | WO1999002674A1 Peptides containing the motif igd and their use as cell migration modulators |
| 01/21/1999 | WO1999002565A2 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 01/21/1999 | WO1999002549A1 Polyol-amino acid compounds having anti-helicobacter pylori activity |
| 01/21/1999 | WO1999002185A1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/21/1999 | WO1999002177A1 Pharmaceutical composition containing peptichemio |
| 01/21/1999 | WO1999002175A1 Conjugates useful in the treatment of prostate cancer |
| 01/21/1999 | WO1999002153A1 Glycol and hydroxyphosphonate peptidomimetics as inhibitors of aspartyl proteases |
| 01/21/1999 | WO1999002146A1 Amino acid derivatives |
| 01/21/1999 | CA2295860A1 Conjugates useful in the treatment of prostate cancer |
| 01/21/1999 | CA2295688A1 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 01/21/1999 | CA2289981A1 Polyol compounds, their production and use |
| 01/20/1999 | EP0891377A1 Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 01/20/1999 | EP0891375A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity |
| 01/20/1999 | CN1205742A Movel process for preparing N-acetyl(L)-4-cyanophenylalanine Ac-(L)-phe(4-CN)-OH and N-acetyl-(L)-p-amidinophenylalantne-cyclohexylglycine-'beta'-(3-N-methylpyridinium)-alanine Ac-(L)-pAph-Chg-PalMe(3 |
| 01/20/1999 | CN1205703A Polymorphic foams of growth hormone secretagogue |
| 01/19/1999 | US5861483 Inhibitor of stem cell proliferation and uses thereof |
| 01/19/1999 | US5861481 Peptide lung surfactants and therapeutic combinations |
| 01/19/1999 | US5861393 Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives |
| 01/19/1999 | US5861380 Oxadiazole, thiadiazole and triazole peptoids as inhibitors of human neutrophil elastase; adult respiratory distress syndrome; antiarthritic,-inflammatory,-ischemic,-tumor and -carcinogenic agents and other hne-mediated conditions |
| 01/19/1999 | US5861375 Compounds for treatment of malaria, toxoplasmosis and coccidiosis |
| 01/19/1999 | US5861284 Method for producing a biologically active recombinant cysteine-free parathyroid hormone (1-34) |
| 01/19/1999 | CA2021179C One-pot process for the preparation of .alpha.-l-aspartyl-l-phenylalaninemethyl ester hydrochloride |
| 01/14/1999 | WO1999001470A2 Peptidomimetic derivatives suicidal inhibitors of the hiv proliferation |
| 01/14/1999 | WO1999001103A2 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 01/13/1999 | EP0890105A1 Methods for diagnosing and treating alzheimer's disease |
| 01/13/1999 | EP0889901A1 Process and intermediates for the synthesis of lhrh antagonists |
| 01/12/1999 | US5859282 Method of dissolving crystals of L-α-aspartyl-L-phenyl alanine methyl ester |
| 01/12/1999 | US5859252 Processes for preparing intermediates of inhibitors of enkephalinase and angiotensin converting enzyme and intermediates thereof |
| 01/12/1999 | US5859239 Mercaptoalkanoylamino and acylmercaptoalkanoylamino benzoxazepines and benzothiazepines |
| 01/12/1999 | US5859210 Boronic compound complexing reagents and complexes |
| 01/12/1999 | US5859191 Method for the site-specific modification of peptide alpha amines |
| 01/12/1999 | US5859190 Solid phase synthesis to form a protected dipeptide followed by reacting with 1,1'-thiocarbonyldiimidazole to effect ring formation; efficiency; anticonvulsant,-arrhythmic and diabetic agents; herbicides and fungicides |
| 01/12/1999 | US5859189 Peptides and polypeptides derived from the submaxillary gland of the rat, corresponding polyclonal and monoclonal antibodies, corresponding hybridomas and uses of these products for diagnosis, for detection or therapeutic purposes |